RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1993; 69(04): 403
DOI: 10.1055/s-0038-1651623
DOI: 10.1055/s-0038-1651623
Letter to the Editor
Factor VIII Inhibitor Associated with Ciprofloxacin
Weitere Informationen
Publikationsverlauf
Received 15. Juli 1992
Accepted after revision 01. Dezember 1992
Publikationsdatum:
05. Juli 2018 (online)
-
References
- 1 Ehrenforth S, Kreuz W, Scharrer I. et al Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-598
- 2 Choe U, Rothschild BM, Laitman L. Ciprofloxacin-induced vasculitis. N Engl J Med 1989; 320: 257-258
- 3 Stubbings J, Sheehan-Dare R. Walton S. Cutaneous vasculitis due to ciprofloxacin. Br Med J 1992; 305: 29
- 4 Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex. Br Med J 1989; 298: 605
- 5 Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet 1989; i: 955-956
- 6 Rodriguez E, Martinez JA, Torres M, Nubiola A, Buges J. Lobular panniculitis associated with ciprofloxacin. Br Med J 1990; 300: 1468
- 7 Mumford CJ, Ginsberg J. Ciprofloxacin and myasthenia gravis. Br Med J 1990; 301: 818